Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Hoffman

Showing results (61-70 of 204) with videos related to

Pageof 21
Sort By:
Cancer Research|April 15, 2010
The effect of CXCL12 processing on CD34+ cell migration in myeloproliferative neoplasmsSool Yeon Cho, Mingjiang Xu, John Roboz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 14, 2016
Psychological Symptoms Among Patients With BCR-ABL-Negative Myeloproliferative NeoplasmsDaniel C McFarland, Heather Polizzi, John Mascarenhas, et al.
Experimental Hematology|December 25, 2012
Stromal cell-mediated inhibition of erythropoiesis can be attenuated by Sotatercept (ACE-011), an activin receptor type II ligand trapCamelia Iancu-Rubin, Goar Mosoyan, Jiapeng Wang, et al.
Blood|March 19, 2009
The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndromeSelcuk Sozer, Maria Isabel Fiel, Thomas Schiano, et al.
Stem Cells Translational Medicine|January 18, 2020
Expansion and preservation of the functional activity of adult hematopoietic stem cells cultured ex vivo with a histone deacetylase inhibitorEran Zimran, Luena Papa, Mansour Djedaini, et al.
Experimental Hematology|December 3, 2014
C-X-C motif chemokine 12 influences the development of extramedullary hematopoiesis in the spleens of myelofibrosis patientsXiaoli Wang, Sool Yeon Cho, Cing Siang Hu, et al.
Cancer Research|September 16, 2009
Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agentsXiaoli Wang, Wei Zhang, Takefumi Ishii, et al.
Cancer Genetics|April 21, 2011
Development of t(8;21) and RUNX1-RUNX1T1 in the Philadelphia-positive clone of a patient with chronic myelogenous leukemia: additional evidence for multiple steps involved in disease progressionVesna Najfeld, Nathaniel Wisch, John Mascarenhas, et al.
Experimental Hematology|September 4, 2007
Behavior of CD34+ cells isolated from patients with polycythemia vera in NOD/SCID miceTakefumi Ishii, Yan Zhao, Selcuk Sozer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 6, 2012
Splenic extramedullary hematopoietic proliferation in Philadelphia chromosome-negative myeloproliferative neoplasms: heterogeneous morphology and cytological compositionSonam Prakash, Ronald Hoffman, Sharon Barouk, et al.
Pageof 21

Showing results (61-70 of 204) with videos related to

Sort By:
Pageof 21
Cancer Research|April 15, 2010
The effect of CXCL12 processing on CD34+ cell migration in myeloproliferative neoplasmsSool Yeon Cho, Mingjiang Xu, John Roboz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 14, 2016
Psychological Symptoms Among Patients With BCR-ABL-Negative Myeloproliferative NeoplasmsDaniel C McFarland, Heather Polizzi, John Mascarenhas, et al.
Experimental Hematology|December 25, 2012
Stromal cell-mediated inhibition of erythropoiesis can be attenuated by Sotatercept (ACE-011), an activin receptor type II ligand trapCamelia Iancu-Rubin, Goar Mosoyan, Jiapeng Wang, et al.
Blood|March 19, 2009
The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndromeSelcuk Sozer, Maria Isabel Fiel, Thomas Schiano, et al.
Stem Cells Translational Medicine|January 18, 2020
Expansion and preservation of the functional activity of adult hematopoietic stem cells cultured ex vivo with a histone deacetylase inhibitorEran Zimran, Luena Papa, Mansour Djedaini, et al.
Experimental Hematology|December 3, 2014
C-X-C motif chemokine 12 influences the development of extramedullary hematopoiesis in the spleens of myelofibrosis patientsXiaoli Wang, Sool Yeon Cho, Cing Siang Hu, et al.
Cancer Research|September 16, 2009
Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agentsXiaoli Wang, Wei Zhang, Takefumi Ishii, et al.
Cancer Genetics|April 21, 2011
Development of t(8;21) and RUNX1-RUNX1T1 in the Philadelphia-positive clone of a patient with chronic myelogenous leukemia: additional evidence for multiple steps involved in disease progressionVesna Najfeld, Nathaniel Wisch, John Mascarenhas, et al.
Experimental Hematology|September 4, 2007
Behavior of CD34+ cells isolated from patients with polycythemia vera in NOD/SCID miceTakefumi Ishii, Yan Zhao, Selcuk Sozer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 6, 2012
Splenic extramedullary hematopoietic proliferation in Philadelphia chromosome-negative myeloproliferative neoplasms: heterogeneous morphology and cytological compositionSonam Prakash, Ronald Hoffman, Sharon Barouk, et al.
Pageof 21